Chronic Obstructive Lung Disease |
DescriptionAn in-depth report on the causes, diagnosis, treatment, and prevention of COPD -- emphysema and/or chronic bronchitis. |
Alternative NamesAlpha-1 Antitrypsin Deficiency; Bronchitis: Chronic; Chronic Bronchitis; Chronic Obstructive Pulmonary Disease; Emphysema |
CausesCigarette smoke accounts for over 80% of all cases of chronic obstructive lung disease. It contains irritants that inflame the air passages, setting off a cascade of biochemical events that damage cells in the lung, increasing the risk both for COLD and lung cancer. Different effects of smoking can lead to emphysema or chronic bronchitis, but smokers generally have signs of both conditions. The diagnosis of a specific type of COLD depends on which disease process predominates. Causes of EmphysemaSmoking is the major cause of emphysema. In some rare inherited disorders, emphysema can develop even in nonsmokers. The Disease Process Leading to Emphysema. The key process leading to emphysema is destruction of a protein in the lung called elastin, which is essential for the "springy" quality of many tissues in the body. This protein is specifically important in the lungs for maintaining flexibility in the alveoli--the tiny sacs at the end of the airways. An imbalance in the following chemicals may be important in this process:
An excess of protease coupled with impaired or deficient AAT can lead to emphysema. Eventually, the imbalance in these factors produces the inelastic walls of the alveoli and the pockets of dead air characteristic of emphysema. Any condition that causes an imbalance in any of these substances may trigger emphysema. Smoking is the major culprit, but genetic factors can also cause this imbalance. Smoking and Biologic Factors Leading to Emphysema. Emphysema caused by smoking most often occurs in the upper lobes of the lungs. Some experts believe that smoking causes an imbalance between AAT and proteases in the following way:
Only 15% to 20 all smokers develop emphysema, however. Other factors, such as genetic abnormalities, may need to be present to increase susceptibility to airway damage. Some genetic factors being investigated are the following:
Alpha 1-Antitrypsin (AAT) Deficiency. An estimated 70,000 people Americans have inherited condition called alpha 1-antitrypsin deficiency (AAT) deficiency that caused emphysema in between 20,000 to 40,000 of them. This disorder results in inadequate amounts of the protective enzyme AAT. Without adequate amounts of AAT, early and progressive damage occurs in both the walls of the alveoli and the airways leading to them. Because smoke is a major toxin and deactivates any residual amounts of AAT, smokers with AAT deficiency have almost no chance of escaping emphysema. Nonsmokers also are at high risk, however. The disease develops in people as young as 30 years old, who are usually of Northern European descent. Screening tests are now available to detect the genetic defect. Couples in which one or both partners have a family history of the disease may wish to be tested for the deficiency, so they may take protective measures for themselves and any future children. If the condition is present in the family, testing the children is important. Causes of Chronic BronchitisBiologic Factors and Smoking in Chronic Bronchitis. In chronic bronchitis, smoking triggers inflammation that causes damage in the airways. The processes involved are less understood than in emphysema, but most likely include the following:
Bacteria and Viruses. Certain bacteria, particularly Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, are common in the lower airways of nearly half of chronic bronchitis patients. However, the role of bacteria, viruses, and other organisms in causing chronic symptoms and inflammation is unclear. Some experts believe that a low-level infection in the lungs may trigger an inflammatory reaction that continues to produce subsequent acute attacks. |
|
|
